scholarly article | Q13442814 |
P2093 | author name string | Juan Ding | |
David A Sullivan | |||
P2860 | cites work | Acromegaly | Q21202912 |
Obesity and the skin: Skin physiology and skin manifestations of obesity | Q22252420 | ||
Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase | Q24310456 | ||
Insulin-like growth factor 1/insulin signaling activates androgen signaling through direct interactions of Foxo1 with androgen receptor | Q24338711 | ||
Control of cell cycle exit and entry by protein kinase B-regulated forkhead transcription factors | Q24537205 | ||
Multiple classes of stem cells in cutaneous epithelium: a lineage analysis of adult mouse skin | Q24545717 | ||
Extending healthy life span--from yeast to humans | Q24599191 | ||
Endocrine parameters and phenotypes of the growth hormone receptor gene disrupted (GHR-/-) mouse | Q24613998 | ||
Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans | Q24618226 | ||
Epidermal homeostasis: a balancing act of stem cells in the skin | Q24654755 | ||
Neutrophil gelatinase-associated lipocalin mediates 13-cis retinoic acid-induced apoptosis of human sebaceous gland cells | Q24657556 | ||
The role of mammalian sirtuins in the regulation of metabolism, aging, and longevity | Q26865526 | ||
Effect of androgen deficiency on the human meibomian gland and ocular surface | Q28141302 | ||
PPARγ Is Required for the Differentiation of Adipose Tissue In Vivo and In Vitro | Q28146187 | ||
Is complete androgen insensitivity syndrome associated with alterations in the meibomian gland and ocular surface? | Q28189953 | ||
Prevalence of dry eye syndrome among US women | Q28196875 | ||
Complete androgen insensitivity syndrome: effect on human meibomian gland secretions | Q28216792 | ||
Resveratrol induces growth arrest and apoptosis through activation of FOXO transcription factors in prostate cancer cells | Q28476510 | ||
Disruption of forkhead transcription factor (FOXO) family members in mice reveals their functional diversification | Q28512492 | ||
Therapeutic potential of resveratrol: the in vivo evidence | Q29547413 | ||
Rejuvenation of aged progenitor cells by exposure to a young systemic environment | Q29615250 | ||
FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress | Q29615562 | ||
The development of meibomian glands in mice | Q33642781 | ||
Prevalence of dry eye disease among US men: estimates from the Physicians' Health Studies | Q33720070 | ||
Resveratrol protects leukemic cells against cytotoxicity induced by proteasome inhibitors via induction of FOXO1 and p27Kip1 | Q33850299 | ||
Metabolic changes in skin caused by Scd1 deficiency: a focus on retinol metabolism | Q33900400 | ||
Role of hormones in pilosebaceous unit development | Q34009592 | ||
Resveratrol inhibits growth of orthotopic pancreatic tumors through activation of FOXO transcription factors | Q34042949 | ||
How much do we really know about our favorite cosmeceutical ingredients? | Q34066235 | ||
Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study | Q34113431 | ||
13-cis-retinoic acid competitively inhibits 3 alpha-hydroxysteroid oxidation by retinol dehydrogenase RoDH-4: a mechanism for its anti-androgenic effects in sebaceous glands? | Q34184730 | ||
Toxic effects of systemic retinoids on meibomian glands | Q34342116 | ||
Peroxisome proliferator-activated receptors and skin development | Q34398377 | ||
13-cis Retinoic acid induces apoptosis and cell cycle arrest in human SEB-1 sebocytes | Q34507245 | ||
FOXO1 represses peroxisome proliferator-activated receptor-gamma1 and -gamma2 gene promoters in primary adipocytes. A novel paradigm to increase insulin sensitivity. | Q34521158 | ||
Effects of 13-cis-retinoic acid on the hamster meibomian gland | Q34561621 | ||
How stem cells age and why this makes us grow old. | Q34667132 | ||
The international workshop on meibomian gland dysfunction: introduction | Q34769291 | ||
The international workshop on meibomian gland dysfunction: report of the subcommittee on anatomy, physiology, and pathophysiology of the meibomian gland | Q34769303 | ||
The international workshop on meibomian gland dysfunction: report of the subcommittee on the epidemiology of, and associated risk factors for, MGD | Q34769309 | ||
Effects of age and dysfunction on human meibomian glands. | Q34919583 | ||
Cutaneous manifestations of endocrine disorders: a guide for dermatologists | Q35104644 | ||
Analysis of the composition of lipid in human meibum from normal infants, children, adolescents, adults, and adults with meibomian gland dysfunction using ¹H-NMR spectroscopy | Q35247603 | ||
Identification of androgen receptor protein and 5alpha-reductase mRNA in human ocular tissues | Q35311828 | ||
Isotretinoin and FoxO1: A scientific hypothesis | Q35558873 | ||
Ocular side effects associated with isotretinoin. | Q35677599 | ||
Growth hormone, insulin and aging: the benefits of endocrine defects | Q36126729 | ||
Stem cells, ageing and the quest for immortality. | Q36523915 | ||
Dynamic FoxO transcription factors | Q36889897 | ||
Characterization of the insulin resistance of aging | Q36989551 | ||
Insulin sensitivity as a key mediator of growth hormone actions on longevity | Q37153969 | ||
Longevity genes: insights from calorie restriction and genetic longevity models. | Q37272412 | ||
Human skin stem cells and the ageing process | Q37276390 | ||
Do sex steroids exert sex-specific and/or opposite effects on gene expression in lacrimal and meibomian glands? | Q37309500 | ||
Age-related changes in the meibomian gland | Q37441381 | ||
The Extending Network of FOXO Transcriptional Target Genes | Q37776729 | ||
Dry skin in the elderly: complexities of a common problem | Q37819196 | ||
The international workshop on meibomian gland dysfunction: executive summary | Q37859542 | ||
Resveratrol and health--a comprehensive review of human clinical trials | Q37891928 | ||
Cosmeceuticals: current trends and market analysis | Q37933940 | ||
Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations | Q39105413 | ||
FOXO3A as a key molecule for all-trans retinoic acid-induced granulocytic differentiation and apoptosis in acute promyelocytic leukemia | Q39730077 | ||
SIRT1 regulates tyrosine hydroxylase expression and differentiation of neuroblastoma cells via FOXO3a | Q39873226 | ||
FoxO1 mediates PTEN suppression of androgen receptor N- and C-terminal interactions and coactivator recruitment | Q39906248 | ||
Resveratrol-containing gel for the treatment of acne vulgaris: a single-blind, vehicle-controlled, pilot study. | Q39972556 | ||
Characterization of bipotential epidermal progenitors derived from human sebaceous gland: contrasting roles of c-Myc and beta-catenin | Q40007688 | ||
Peroxisome proliferator-activated receptors increase human sebum production | Q40283470 | ||
Convergence of peroxisome proliferator-activated receptor gamma and Foxo1 signaling pathways | Q40635898 | ||
Down-regulation of androgen receptor expression and inhibition of lacrimal gland cell proliferation by retinoic acid | Q40686748 | ||
13-cis retinoic acid exerts its specific activity on human sebocytes through selective intracellular isomerization to all-trans retinoic acid and binding to retinoid acid receptors | Q40860130 | ||
The transcription of FOXO genes is stimulated by FOXO3 and repressed by growth factors | Q42067514 | ||
Conjunctival impression cytology, ocular surface, and tear-film changes in patients treated with systemic isotretinoin | Q42446769 | ||
Role of resveratrol in FOXO1-mediated gluconeogenic gene expression in the liver | Q42813390 | ||
Lacrimal function and ocular complications in patients treated with systemic isotretinoin. | Q44061070 | ||
Androgen control of gene expression in the rabbit meibomian gland. | Q44339203 | ||
Involvement of the SREBP pathway in the mode of action of androgens in sebaceous glands in vivo | Q44557334 | ||
Deletion, but not antagonism, of the mouse growth hormone receptor results in severely decreased body weights, insulin, and insulin-like growth factor I levels and increased life span | Q44559269 | ||
Evaluation of the clinical course of dry eye syndrome | Q44616226 | ||
Interactions of testosterone and all-trans retinoic acid in regulation of androgen receptor expression in rat lacrimal gland | Q44650083 | ||
Age-related morphological changes in lid margin and meibomian gland anatomy | Q45059006 | ||
Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation | Q46220928 | ||
Drug-induced ocular side-effects with isotretinoin | Q46398952 | ||
Androgen control of gene expression in the mouse meibomian gland | Q46722430 | ||
The aging of hematopoietic stem cells | Q46785776 | ||
Noncontact infrared meibography to document age-related changes of the meibomian glands in a normal population | Q47734345 | ||
Premature ageing in transgenic mice expressing different growth hormone genes | Q48386543 | ||
Expressibility of meibomian secretion. Relation to age, lipid precorneal film, scales, foam, hair and pigmentation | Q69102465 | ||
Steroid hormone receptors and their relevance for sebum production in the sebaceous gland ear model of the Syrian hamster | Q71023500 | ||
Ocular surface changes and discomfort in patients with meibomian gland dysfunction | Q71780207 | ||
Impact of androgen deficiency on the lipid profiles in human meibomian gland secretions | Q73071822 | ||
Androgen influence on the meibomian gland | Q73127914 | ||
Turnover and migration of meibomian gland cells in rats' eyelids | Q73844052 | ||
Involvement of follicular stem cells in forming not only the follicle but also the epidermis | Q74244902 | ||
Growth hormone and insulin-like growth factors have different effects on sebaceous cell growth and differentiation | Q78180919 | ||
Anatomy and histopathology of human meibomian gland | Q78670320 | ||
Association between meibomian gland changes and aging, sex, or tear function | Q79320056 | ||
Proposed mechanisms of action for retinoid derivatives in the treatment of skin aging | Q79433191 | ||
Influence of aging on the polar and neutral lipid profiles in human meibomian gland secretions | Q80243890 | ||
The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007) | Q80347907 | ||
Androgen influence on cholesterogenic enzyme mRNA levels in the mouse meibomian gland | Q80359894 | ||
Committed differentiation of hair follicle bulge cells into sebocytes: an in vitro study. | Q50553506 | ||
Testosterone metabolism to 5alpha-dihydrotestosterone and synthesis of sebaceous lipids is regulated by the peroxisome proliferator-activated receptor ligand linoleic acid in human sebocytes. | Q50705226 | ||
Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men. | Q50961169 | ||
Targeted disruption of stearoyl-CoA desaturase1 gene in mice causes atrophy of sebaceous and meibomian glands and depletion of wax esters in the eyelid. | Q52543944 | ||
[Meibomian glands : part III. Dysfunction - argument for a discrete disease entity and as an important cause of dry eye]. | Q52907021 | ||
Isotretinoin revisited: pluripotent effects on human sebaceous gland cells. | Q53598493 | ||
Resveratrol upregulated SIRT1, FOXO1, and adiponectin and downregulated PPARγ1-3 mRNA expression in human visceral adipocytes. | Q54409421 | ||
Effects of long-term elevated serum levels of growth hormone on life expectancy of mice: Lessons from transgenic animal models | Q57198146 | ||
Androgen regulation of lipogenic pathways in the mouse meibomian gland | Q64004725 | ||
Sebum excretion in acromegaly | Q68637345 | ||
A longitudinal study of the relationship of plasma somatomedin-C concentration to the pubertal growth spurt | Q69009079 | ||
P433 | issue | 7 | |
P921 | main subject | eye disease | Q3041498 |
P304 | page(s) | 483-490 | |
P577 | publication date | 2012-04-28 | |
P1433 | published in | Experimental Gerontology | Q15766996 |
P1476 | title | Aging and dry eye disease | |
P478 | volume | 47 |
Q57484944 | A Phase II/III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease |
Q55280295 | A novel system, TearCare®, for the treatment of the signs and symptoms of dry eye disease. |
Q35773063 | Age-related Defects in Ocular and Nasal Mucosal Immune System and the Immunopathology of Dry Eye Disease |
Q57814418 | An Eyelid Warming Device for the Management of Meibomian Gland Dysfunction |
Q34043708 | Androgen deficiency and dry eye syndrome in the aging male |
Q50086774 | Blink: Characteristics, Controls, and Relation to Dry Eyes. |
Q48138863 | Changes in Distribution of Dry Eye Disease by the New 2016 Diagnostic Criteria from the Asia Dry Eye Society. |
Q36867022 | Characterization of Rat Meibomian Gland Ion and Fluid Transport. |
Q100945976 | Diagnostic ability of maximum blink interval together with Japanese version of Ocular Surface Disease Index score for dry eye disease |
Q55112422 | Efficacy of intra-meibomian gland injection of the anti-VEGF agent bevacizumab for the treatment of meibomian gland dysfunction with lid-margin vascularity. |
Q38905054 | External eye symptoms in indoor environments |
Q54081258 | Factors associated with mucosal dryness in multiple regions and skin: A web-based study in women. |
Q55101249 | Glaucoma therapy: preservative-free for all? |
Q36626322 | Growth Hormone Influence on the Morphology and Size of the Mouse Meibomian Gland. |
Q64229464 | Health Benefits of Polyphenols and Carotenoids in Age-Related Eye Diseases |
Q37164943 | Hormone replacement therapy benefits meibomian gland dysfunction in perimenopausal women |
Q41015875 | Intense pulsed light for evaporative dry eye disease |
Q37662097 | Interferon-gamma deficiency protects against aging-related goblet cell loss. |
Q41064508 | Loss of CD147 results in impaired epithelial cell differentiation and malformation of the meibomian gland. |
Q58759867 | Maximum blink interval is associated with tear film breakup time: A new simple, screening test for dry eye disease |
Q38058002 | New agents for treating dry eye syndrome. |
Q39738019 | One man's poison is another man's meat: using azithromycin-induced phospholipidosis to promote ocular surface health |
Q41785810 | Optical Coherence Tomography Reveals Changes to Corneal Reflectivity and Thickness in Individuals with Tear Hyperosmolarity |
Q34438211 | Prevalence of and risk factors for dry eye symptom in mainland china: a systematic review and meta-analysis |
Q33650494 | Prospective evaluation of intense pulsed light and meibomian gland expression efficacy on relieving signs and symptoms of dry eye disease due to meibomian gland dysfunction |
Q39174470 | Proteolytic activity in the meibomian gland: Implications to health and disease |
Q50034049 | Relation Between Dietary Essential Fatty Acid Intake and Dry Eye Disease and Meibomian Gland Dysfunction in Postmenopausal Women. |
Q37443668 | Risk Factors and Symptoms of Meibomian Gland Loss in a Healthy Population. |
Q90243372 | Seeing ophthalmologic problems in Parkinson disease: Results of a visual impairment questionnaire |
Q88735143 | Subconjunctival dendrimer-drug therapy for the treatment of dry eye in a rabbit model of induced autoimmune dacryoadenitis |
Q34222194 | Superoxide dismutase 1 loss disturbs intracellular redox signaling, resulting in global age-related pathological changes |
Q61811564 | TearCare system extension study: evaluation of the safety, effectiveness, and durability through 12 months of a second TearCare treatment on subjects with dry eye disease |
Q64950112 | The role of autophagy in the pathogenesis of exposure keratitis. |
Q26822610 | Therapeutic Strategies to Treat Dry Eye in an Aging Population |
Search more.